
CAR T-Cell Pioneer Plots Technology’s Next Steps
Renier Brentjens, MD, PhDRenier Brentjens, MD, PhD, one of the pioneers in the development of chimeric antigen receptor (CAR) T-cell therapy, is poised to see the technology take its next big leap, with researchers testing new targets and new designs and …